CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Leerink Swann Cancer Roundtable Conference being held at the Roosevelt Hotel in New York City, New York on Thursday, April 7, 2011. Harvey J. Berger, M.D., chairman and chief executive officer at ARIAD, will provide an overview of the Company’s strong oncology pipeline and progress on its three lead compounds at 3:30 p.m. (ET). Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer at ARIAD, will participate on a lymphoma and leukemia discussion panel at 2:15 p.m. (ET).
